Therapeutic Asset Ratings
6,538 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Diffuse Large B-Cell Lymphoma
Beth Israel Deaconess Medical Center
P4
BBB
(73)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
P4
BBB
(73)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Multiple Sclerosis, Relapsing-Remitting
Universitätsklinikum Hamburg-Eppendorf
P4
BBB
(73)
PANITUMUMAB
Oncology
Astellas Pharma Inc
P2
BBB
(73)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Burkitt Lymphoma
AIDS Malignancy Consortium
P4
BBB
(72)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Recurrent Adult Acute Lymphoblastic Leukemia
University of Washington
P4
BBB
(72)
Nivolumab
Metastatic Kidney Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
P4
BBB
(72)
Ublituximab
Multiple Sclerosis (MS) - Relapsing-remitting
TG Therapeutics, Inc.
P4
BBB
(72)
Blinatumomab
B Cell Precursor Acute Lymphoblastic Leukemia
Amgen
P3
BBB
(72)
Blinatumomab
Philadelphia Chromosome-Positive
Novartis Pharmaceuticals
P3
BBB
(72)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Inflammatory Breast Cancer
Hoffmann-La Roche
P3
BBB
(72)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
City of Hope Medical Center
P3
BBB
(72)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Refractory Diffuse Large B-Cell Lymphoma
Sun Yat-sen University
P3
BBB
(72)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Intraocular Lymphoma
Peking Union Medical College Hospital
P2
BBB
(72)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Post-transplant Lymphoproliferative Disorder
Jennifer Amengual
P2
BBB
(72)
Pembrolizumab
HER2/Neu Negative
UNC Lineberger Comprehensive Cancer Center
P2
BBB
(72)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
HER2-positive Breast Cancer
SWOG Cancer Research Network
P4
BB
(71)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
ALL, Childhood
Peking Union Medical College Hospital
P4
BB
(71)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Lymphoma, B-Cell
Mwanasha Merrill, MD
P4
BB
(71)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Marginal Zone Lymphoma
City of Hope Medical Center
P4
BB
(71)
LECANEMAB
Alzheimer's Disease
Second Affiliated Hospital, School of Medicine, Zhejiang University
P4
BB
(71)
MOGAMULIZUMAB
Cutaneous T Cell Lymphoma
University of Michigan Rogel Cancer Center
P4
BB
(71)
Ipilimumab
Metastatic Tumor
7 Hills Pharma, LLC
P3
BB
(71)
Obinutuzumab
Chronic Lymphocytic Leucemia
Paolo Caimi, MD
P3
BB
(71)
MOGAMULIZUMAB
Adult T-cell Leukemia-Lymphoma
Memorial Sloan Kettering Cancer Center
P2
BB
(71)
Showing 26 to 50 of 6,538 assets
Previous
Page 2 of 262
Next